Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39516 |
Bocidelpar
|
PPAR | DNA Damage/DNA Repair; Metabolism |
Bocidelpar 是一种有效的过氧化物酶体增殖物激活受体 delta 调节剂,可改善杜兴肌营养不良肌肉细胞中的线粒体生物合成和功能。 | |||
T11062 |
dmDNA31
|
Others | Others |
dmDNA31 is a rifamycin antibiotic that can inhibit the DNA-dependent RNA polymerase of bacteria and has strong bactericidal activity against Staphylococcus aureus. | |||
T15945 |
MA-0204
|
PPAR | DNA Damage/DNA Repair; Metabolism |
MA-0204 是一种高选择性,可口服的过氧化物酶体增殖物激活受体 δ (PPARδ) 调节剂,对于人,小鼠和大鼠 PPARδ 的 EC50分别为 0.4、7.9 和 10 nM。它有用于 Duchene 肌营养不良症 (DMD) 的研究潜力。 | |||
T3424 |
Ezutromid
BMN 195,VOX-C1100,依珠曲米,SMT C1100 |
Others | Others |
Ezutromid (BMN 195) 是一种具有口服活性的、首创的苯并恶唑 utrophin 调节剂,EC50=0.91 μM。它抑制人肝微粒体 CYP1A2 酶活性,IC50=5.4 μM。它可用于 Duchenne 型肌营养不良症 (DMD) 的研究。 | |||
T60594 | OX01914 | ||
OX01914 是一种水溶性和细胞膜可渗透的 utrophin 调节剂,能够上调 utrophin 蛋白水平,EC50值为 20.5 μM。 OX01914 可用于研究杜氏肌肉营养不良症(DMD)。 | |||
T39517 |
Suvodirsen
WVE-210201 |
||
Suvodirsen (WVE-210201) is an oligonucleotide compound with potential applications in the study of Duchenne muscular dystrophy (DMD). | |||
T66481 |
TG-693
|
||
TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skipped dystrophin protein. | |||
T14129 |
Adenylosuccinic acid
Aspartyl adenylate,Adenylosuccinate |
Others | Others |
Adenylosuccinic acid (Adenylosuccinate; Aspartyl adenylate) is a purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid has the potential for the study of duchenne muscular dystrophy(DMD)[1] and can be co | |||
T38860 |
Golodirsen
Golodirsen,SRP-4053 |
||
Golodirsen (SRP-4053) is a phosphorodiamidate morpholino oligomer (PMO) designed to selectively bind and target exon 53 of dystrophin pre-mRNA, with applications in the investigation of Duchenne muscular dystrophy (DMD). | |||
T75137 | BAY-747 | ||
BAY-747 (BAY 1165747) 为一种通过口服生效且具有脑渗透性的sGC刺激剂。它能可逆地逆转L-NAME所诱导的记忆障碍并在大鼠中增强认知功能。BAY-747还可在有意识状态下降低正常血压及自发性高血压大鼠(SHR)的血压。此外,BAY-747在mdx/mTRG2小鼠模型中改善了与Duchenne肌营养不良症(DMD)相关的骨骼肌功能。 | |||
T39455 |
Viltolarsen
NS-065,NCNP-01 |
||
Viltolarsen (NS-065/NCNP-01) is a phosphorodiamidate morpholino antisense oligonucleotide that specifically targets the splicing of exon 53 in the dystrophin gene. It is utilized in research related to Duchenne muscular dystrophy (DMD). | |||
T61645 |
Utrophin modulator 1
|
||
Utrophin Modulator 1 (UM1) is a highly effective agent that upregulates utrophin protein levels, displaying an EC 50 of 0.11 μM. Its application in the investigation of Duchenne Muscular Dystrophy (DMD) has been well-established [1]. | |||
T38859 |
Casimersen
SRP-4045 |
||
Casimersen (SRP-4045) is an antisense oligonucleotide, specifically belonging to the phosphorodiamidate morpholino oligomer subclass. It binds to exon 45 of dystrophin pre-mRNA, effectively restoring the open-reading frame by skipping exon 45. This action ultimately leads to the production of a functional dystrophin protein, albeit internally truncated. Casimersen finds utility in Duchenne muscular dystrophy (DMD) research. | |||
T73919 | Adenylosuccinic acid tetraammonium | ||
Adenylosuccinic acid tetraammonium(Adenylosuccinate; Aspartyl adenylate)是一种在核苷酸循环代谢中起作用的口服活性嘌呤核糖核苷单磷酸。该化合物可通过腺苷琥珀酸裂解酶转化为富马酸,展现出在杜氏肌营养不良症(DMD)研究中的应用潜力。 | |||
T41267 |
PROTAC(H-PGDS)-7
|
||
PROTAC(H-PGDS)-7 是一种有选择性的、有效的小分子造血前列腺素 D 合酶 (H-PGDS)PROTAC 降解剂,在 KU812细胞中展现出降解活性,DC50为 17.3 pM。PROTAC(H-PGDS)-7是一种类药化合物,能有效抑制前列腺素 D2 (PGD2)的产生,抑制炎症因子重生作用。PROTAC(H-PGDS)-7是治疗 DMD 和其他H-PGDS 相关疾病的候选化合物。 | |||
T37880 |
OPC-167832
|
||
OPC-167832 is a potent and orally active dprE1 Inhibitor with an IC50 of 0.258 μM. OPC-167832 has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis[1]. OPC-167832 exhibits very low MICs against laboratory strains of M. tuberculosis H37Rv (MIC: 0.0005 μg/ml) and Kurono (MIC: 0.0005 μg/ml) and strains with monoresistance to rifampin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STR), and pyrazinamide (PZA) (MIC: 0.00024-0.001 ... |